Crystal forms of tetrahydro-n,n-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride, processes of making such forms, and their pharmaceutical compositions
AssigneeAnavex Life Sciences Corp.
InventorsLinda Sharon Daintree, Daniel Mark Ledger, Lucy Anne Leonard, Peter York, Alani Selvey
Life of this patent
Estimating the term…
Abstract
Polymorphic forms of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) and a metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73) are disclosed and characterized. Compositions and method for treatment of Alzheimer's disease that includes the polymorphic forms and metabolite of tetrahydro-N,N-dimethyl-2,2-diphenyl-3-furanmethanamine hydrochloride (ANAVEX2-73).
Claims4
A method of making crystalline Form I, Form II or Form III of ANAVEX2-73, comprising crystallizing ANAVEX2-73 in a supercritical fluid (SCF) environment, wherein the supercritical fluid comprises supercritical carbon dioxide.
Dependencies are inferred from the claim text.